Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Histopathology ; 80(2): 369-380, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34523152

RESUMO

AIMS: Amplification of the murine double minute-2 (MDM2) gene, which is usually detected with fluorescence in-situ hybridisation (FISH), is the key driving event for atypical lipomatous tumours (ALTs)/well-differentiated liposarcomas (WDLs). We sought to determine the concordance between the histopathological findings and MDM2 FISH in the diagnosis of ALT/WDL, and to identify the histological features of MDM2-amplified tumours lacking classic atypia. METHODS AND RESULTS: We performed a retrospective analysis of all mature lipomatous lesions subjected to MDM2 FISH analysis at our institution. MDM2 FISH analysis was performed on 439 mature lipomatous lesions: 364 (82.9%) were negative and 75 (17%) were positive. In 17 of 75 (22.6%) ALTs/WDLs, cytological atypia was not identified on initial histological assessment, thus favouring lipoma. On review, these cases shared common histological features, consisting of a very low number of relatively small stromal cells within the tumour lobules, with mildly coarse chromatin and oval nuclei, admixed with unremarkable adipocytes in a tumour background devoid of fibroconnective septa, areas of fibrosis, or blood vessels. These cells matched the cells in which FISH showed MDM2 amplification. In contrast, 13 cases (3.5%) regarded as suspicious for ALT/WDL on the basis of histology lacked MDM2 amplification and were reclassified following the FISH findings. CONCLUSIONS: We conclude that a subset of lipoma-like ALTs/WDLs are not associated with any of the features typically described in ALT/WDL. Our study also showed that tumours >100 mm are more likely to be ALT/WDL; however, a history of recurrence or concerning clinical/radiological features was not significantly associated with classification as ALT/WDL.


Assuntos
Lipoma/metabolismo , Lipossarcoma/metabolismo , Proteínas Proto-Oncogênicas c-mdm2/metabolismo , Neoplasias de Tecidos Moles/metabolismo , Adulto , Idoso , Humanos , Hibridização in Situ Fluorescente , Lipoma/genética , Lipoma/patologia , Lipossarcoma/genética , Lipossarcoma/patologia , Pessoa de Meia-Idade , Proteínas Proto-Oncogênicas c-mdm2/genética , Estudos Retrospectivos , Neoplasias de Tecidos Moles/genética , Neoplasias de Tecidos Moles/patologia
2.
Int J Surg Pathol ; 30(4): 462-465, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-34955058

RESUMO

MYC over-expression by immunohistochemistry (IHC) is utilised in routine pathology practice as a surrogate marker for MYC amplification, which plays a key oncogenic role in post-irradiation and chronic lymphedema-associated angiosarcoma. We present the case of a 32-year old male, who presented with high-grade angiosarcoma arising in a background of metastatic testicular teratoma. IHC for MYC showed strong nuclear expression in the angiosarcoma cells prompting the consideration of post-irradiation-induced angiosarcoma but our patient did not undergo radiotherapy. Fluorescence in-situ hybridization (FISH) excluded MYC amplification and instead showed Chromosome 8 polysomy, which accounted for the strong MYC IHC expression present, not previously described in the context of germ cell tumours. The occurrence of MYC over-expression due to polysomy illustrates a novel clinical scenario (angiosarcoma arising as somatic malignancy) where strong MYC IHC expression can be found in the absence of underlying amplification or prior radiotherapy exposure.


Assuntos
Hemangiossarcoma , Segunda Neoplasia Primária , Teratoma , Cromossomos Humanos Par 8/genética , Cromossomos Humanos Par 8/metabolismo , Amplificação de Genes , Hemangiossarcoma/genética , Hemangiossarcoma/patologia , Humanos , Masculino , Segunda Neoplasia Primária/genética , Proteínas Proto-Oncogênicas c-myc/genética , Teratoma/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...